Free Trial

Owens & Minor (NYSE:OMI) Issues FY24 Earnings Guidance

Owens & Minor logo with Medical background

Owens & Minor (NYSE:OMI - Get Free Report) issued an update on its FY24 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.45-1.55 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $10.6-10.8 billion, compared to the consensus revenue estimate of $10.71 billion. Owens & Minor also updated its FY 2024 guidance to 1.450-1.550 EPS.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Citigroup raised Owens & Minor from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $24.00 to $19.00 in a report on Friday, July 19th. StockNews.com downgraded shares of Owens & Minor from a "buy" rating to a "hold" rating in a research note on Monday, August 26th. Robert W. Baird cut their price target on shares of Owens & Minor from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Tuesday, July 16th. JPMorgan Chase & Co. decreased their price objective on shares of Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a research note on Wednesday, August 21st. Finally, Barclays cut their target price on Owens & Minor from $23.00 to $18.00 and set an "equal weight" rating for the company in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Owens & Minor presently has a consensus rating of "Hold" and an average price target of $20.00.

Read Our Latest Analysis on Owens & Minor

Owens & Minor Trading Down 10.2 %

Owens & Minor stock traded down $1.36 during trading hours on Monday, reaching $12.00. 2,051,715 shares of the company's stock were exchanged, compared to its average volume of 832,902. The firm has a market capitalization of $925.20 million, a PE ratio of -21.43, a PEG ratio of 0.41 and a beta of 0.41. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17. The firm's 50 day simple moving average is $14.62 and its 200 day simple moving average is $16.28. Owens & Minor has a twelve month low of $11.75 and a twelve month high of $28.35.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its earnings results on Friday, August 2nd. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.03. The company had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.65 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The firm's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.18 EPS. Research analysts predict that Owens & Minor will post 1.57 earnings per share for the current year.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Further Reading

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix is shaking up the streaming world again with its new ad-supported tier, leading to a surge in subscribers and revenue.

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines